Skip Navigation

Reinventing the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

Excerpts from an editorial by Linda Birnbaum, Director of the US National Institute on Environmental Health Sciences (NIEHS):

In 1997, the National Institute of Environmental Health Sciences (NIEHS) established the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), an ad hoc federal interagency committee to address the growing need for obtaining regulatory acceptance of new toxicological test methods. The thought was that simultaneous agency evaluation of new methods that addressed the 3Rs (reduction, refinement, and replacement) of animal testing by an interagency group could greatly speed up and harmonize the cross-agency acceptance and adoption of new methods into federal toxicity testing guidelines. This activity was codified into law in 2000 by passage of the ICCVAM Authorization Act (2000). The Act specified 15 agencies (such as the Food and Drug Administration, U.S. Environmental Protection Agency, Consumer Product Safety Commission, Department of Transportation, Occupational Safety and Health Administration, and U.S. Department of Agriculture) that would constitute ICCVAM. The Act also prescribed specific duties intended to facilitate review and acceptance of test methods, established an external scientific advisory committee, and required the director of the NIEHS to establish ICCVAM under the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), which currently exists as a functional unit within the Division of the NTP at the NIEHS.

The NIEHS is beginning to move forward with a different philosophy toward ICCVAM. Rather than the NIEHS directing the activities of ICCVAM through NICEATM, the interagency agenda will now be driven by the partner regulatory agencies--the agencies that will ultimately implement the ICCVAM-recommended methods. Regulatory agencies are required by statute to use toxicology test information for a variety of purposes, including labeling and registration, and these requirements are not uniform. The ICCVAM Authorization Act acknowledges that some alternative test methods promoted by ICCVAM, while deemed valid, may not meet specific needs of a regulatory agency. With ICCVAM regulatory agencies taking ownership of the process, there should be a better match between the alternative test methods validated and the tests required to meet regulatory guidelines.

Toxicology testing is shifting from a primary focus on adverse phenotypic observations in animals to mechanism-based biological outcomes in vitro, and the NIEHS is embracing this paradigm shift through its participation in the multiagency Tox21 consortium (Collins et al. 2008). NICEATM will expand its scope and concentrate its resources on providing bioinformatic and computational toxicology support to NIEHS Tox21 projects.

With its purpose of transforming toxicology by shifting from in vivo animal studies to in vitro assays, in vivo assays in lower organisms, and computational modeling for toxicity assessments, Tox21 has the real potential to result in dramatic changes in the numbers and types of organisms used for toxicology testing. A stronger interface of NICEATM with Tox21 will better position ICCVAM for addressing how data from these new methods can be integrated into the existing regulatory framework.

Read the Full Editorial

New ALTEX: 1/2016

ALTEX 2.16 cover

Support ALTWEB, Make a Gift
Online Humane Science Course

MeetingS

 
Promoting Dialogue Between In Vivo, In Vitro, and In Silico
May 18, 2016
Milan, Italy
mailto:acu@marionegri.it

SOT In Vitro and Alternatives Methods Speciality Section Grad Student and Postdoc Webinar
May 18, 2016
11am EDT

Mucosal Immunity and In Vitro Science
May 19, 2016
Milan, Italy

CAAT Academy: In Silico Modeling and Tools Under REACH 
May 20, 2016
Hosted by ROCAM in Cluj, Romania
Registration and Information

ACTC 2016 Conference
May 30-June 1, 2016
Barcelona, Spain

Kirkstall Workshop
June 2-3, 2016
Barcelona, Spain
oana.voloaca@kirkstall.org

CAAT Academy: Animal-free Pyrogenicity and Endotoxin Testing Under the New EU Pharmacopeia Chapter 5.1.10
June 8th, 2016
Konstanz, Germany 
 
17th International Conference on QSAR in Environmental and Health Sciences (QSAR 2016)
June 13-17, 2016
Miami Beach, Florida

17th Annual Congress of EUSAAT/20th European Congress on Alternatives to Animal Testing
August 24-27, 2016
University of Linz, Austria

ESTIV 2016 Congress: In Vitro Toxicology for Human Safety Assessment
October 17-20, 2016
Juan-les-Pins, France

AALAS 67th Annual Meeting
October 30-November 3, 2016
Charlotte, NC

SAVE THE DATE:
10th World Congress on Alternatives and Animal Use in the Life Sciences
August 20-24, 2017
Seattle, Washington
 

More Meetings...